cyclosporine has been researched along with Liver Diseases, Alcoholic in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, J; Cederbaum, AI | 1 |
Dudley, T; Haydon, G; Mutimer, D; Nightingale, P; Oo, YH | 1 |
Kaplan, MM; Pedrosa, MC; Rohrer, RM | 1 |
Harrison, D; Holland, BK; Holman, MJ; Ippolito, T; Koneru, B; Leevy, CB; Rizwan, M | 1 |
Cahill, A; Hoek, JB; Marcineviciute, A; Pastorino, JG | 1 |
5 other study(ies) available for cyclosporine and Liver Diseases, Alcoholic
Article | Year |
---|---|
Overexpression of CYP2E1 in mitochondria sensitizes HepG2 cells to the toxicity caused by depletion of glutathione.
Topics: Aldehydes; Animals; Antioxidants; Blotting, Western; Buthionine Sulfoximine; Catalysis; Cell Line; Cell Survival; Cyclosporine; Cytochrome P-450 CYP2E1; DNA, Complementary; Endoplasmic Reticulum; Ethanol; Flow Cytometry; Glutathione; Humans; Liver; Liver Diseases, Alcoholic; Male; Membrane Potentials; Microscopy, Confocal; Mitochondria; Mitochondria, Liver; Oxidative Stress; Plasmids; Rats; Rats, Sprague-Dawley; Subcellular Fractions; Time Factors; Transfection; Tyrosine | 2006 |
Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation.
Topics: Adult; Aged; Biopsy; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Diseases, Alcoholic; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Tacrolimus; Treatment Outcome | 2008 |
Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
Topics: Adolescent; Adult; Aged; Azathioprine; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cholangitis, Sclerosing; Cushing Syndrome; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Incidence; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases, Alcoholic; Liver Failure, Acute; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Prednisone | 1995 |
Blood transfusions in liver recipients: a conundrum or a clear benefit in the cyclosporine/tacrolimus era?
Topics: Adult; Blood Transfusion; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Intraoperative Period; Liver Diseases, Alcoholic; Liver Failure; Liver Transplantation; Male; Middle Aged; Tacrolimus; Time Factors | 1997 |
Potentiation by chronic ethanol treatment of the mitochondrial permeability transition.
Topics: Alcoholism; Animals; Apoptosis; bcl-2-Associated X Protein; Calcium; Ceramides; Cyclosporine; Ethanol; Gangliosides; In Vitro Techniques; Liver Diseases, Alcoholic; Male; Mitochondria, Liver; Mitochondrial Swelling; Necrosis; Permeability; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley | 1999 |